TP53 and Hodgkins lymphoma: The combination of nutlin-3 with Hsp90 inhibitors has previously demonstrated synergism in solid tumors [24], while nutlin-3 and geldamamycin exhibited various effects in classical Hodgkin’s lymphoma depending on TP53 mutational status [58].